CRVO · CervoMed Inc. Common Stock
View on chartInsiders & Stakes
| BOGER JOSHUA S Director | ▲ Buy | Open Market | 1,795,865 Shares held | 6/11/2026 | View profile |
| Winton Matthew Chief Commercial and Business | ▲ Buy | Open Market | 15,000 Shares held | 11/18/2025 | View profile |
| Gregoire Sylvie Director | ▲ Buy | Open Market | 12,500 Shares held | 11/17/2025 | View profile |
| ELDER WILLIAM ROBERT GC & Secretary | ▲ Buy | Open Market | 12,500 Shares held | 11/18/2025 | View profile |
| ALAM JOHN J CEO & President | ▲ Buy | Open Market | 12,500 Shares held | 11/17/2025 | View profile |
| Cobuzzi Robert Joseph Jr. President & CEO | ▼ Sell | Other | 1,616 Shares held | 1/31/2023 | View profile |
| Hollingsworth Jane H Director | ▼ Sell | Other | 898 Shares held | 8/31/2023 | View profile |
| LANCHONEY DIANA M Director | ▼ Sell | Other | 294 Shares held | 6/30/2023 | View profile |
Transaction History
| BOGER JOSHUA S | ▲ Buy | Open Market | 955,414 | $3.0M | 6/11/2026 |
| Winton Matthew | ▲ Buy | Open Market | 1,500 | $12K | 11/18/2025 |
| ELDER WILLIAM ROBERT | ▲ Buy | Open Market | 2,500 | $21K | 11/18/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 10,807 | $91K | 11/17/2025 |
| ELDER WILLIAM ROBERT | ▲ Buy | Open Market | 1,000 | $8K | 11/17/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 10,807 | $91K | 11/17/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 10,793 | $91K | 11/17/2025 |
| Winton Matthew | ▲ Buy | Open Market | 3,500 | $30K | 11/17/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 10,793 | $91K | 11/17/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 1,707 | $13K | 11/14/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 1,693 | $13K | 11/14/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 1,693 | $13K | 11/14/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 1,707 | $13K | 11/14/2025 |
| Winton Matthew | ▲ Buy | Open Market | 10,000 | $76K | 11/14/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 4,447 | $33K | 11/13/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 4,447 | $33K | 11/13/2025 |
| Gregoire Sylvie | ▲ Buy | Open Market | 5,553 | $41K | 11/12/2025 |
| ELDER WILLIAM ROBERT | ▲ Buy | Open Market | 3,500 | $26K | 11/12/2025 |
| ALAM JOHN J | ▲ Buy | Open Market | 5,553 | $41K | 11/12/2025 |
| ELDER WILLIAM ROBERT | ▲ Buy | Open Market | 4,233 | $36K | 5/14/2025 |
| ELDER WILLIAM ROBERT | ▲ Buy | Open Market | 1,000 | $18K | 8/27/2024 |
| BOGER JOSHUA S | ▼ Sell | Open Market | 36 | — | 2/26/2024 |
| BOGER JOSHUA S | ▼ Sell | Other | 495,995 | — | 2/26/2024 |
| Gregoire Sylvie | ▼ Sell | Gift | 10,000 | $0 | 11/9/2023 |
| ALAM JOHN J | ▼ Sell | Gift | 12,500 | $0 | 11/9/2023 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 122 | — | 8/31/2023 |
| Hollingsworth Jane H | ▼ Sell | Other | 45 | — | 8/31/2023 |
| LANCHONEY DIANA M | ▲ Buy | Option Exercise | 232 | — | 6/30/2023 |
| LANCHONEY DIANA M | ▼ Sell | Other | 85 | — | 6/30/2023 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 183 | — | 5/31/2023 |
| Hollingsworth Jane H | ▼ Sell | Other | 68 | — | 5/31/2023 |
| LANCHONEY DIANA M | ▲ Buy | Option Exercise | 232 | — | 3/31/2023 |
| LANCHONEY DIANA M | ▼ Sell | Other | 85 | — | 3/31/2023 |
| Hollingsworth Jane H | ▼ Sell | Other | 68 | — | 2/28/2023 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 183 | — | 2/28/2023 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 327 | — | 1/31/2023 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 121 | — | 1/31/2023 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 183 | — | 11/30/2022 |
| Hollingsworth Jane H | ▼ Sell | Other | 68 | — | 11/30/2022 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 121 | — | 10/31/2022 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 327 | — | 10/31/2022 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 183 | — | 8/31/2022 |
| Hollingsworth Jane H | ▼ Sell | Other | 67 | — | 8/31/2022 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 121 | — | 8/1/2022 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 327 | — | 8/1/2022 |
| Hollingsworth Jane H | ▲ Buy | Option Exercise | 183 | — | 5/31/2022 |
| Hollingsworth Jane H | ▼ Sell | Other | 67 | — | 5/31/2022 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 327 | — | 5/2/2022 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 121 | — | 5/2/2022 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 100 | $3K | 4/18/2022 |
| ELDER WILLIAM ROBERT | ▼ Sell | Other | 100 | $3K | 4/18/2022 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 16,350 | — | 1/31/2022 |
| Cobuzzi Robert Joseph Jr. | ▼ Sell | Other | 6,049 | — | 1/31/2022 |
| Cobuzzi Robert Joseph Jr. | ▲ Buy | Option Exercise | 16,350 | — | 11/1/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
CervoMed Reports PK Data and FDA Removal of Exposure Limit
CervoMed announced pharmacokinetic results for its new oral tablet formulation of neflamapimod. The company also secured the FDA's removal of a drug exposure limit, a regulatory update that may affect future development steps. These developments provide context for the stock's recent price movement within its 52-week range.
CervoMed Reports PK Data and FDA Removal of Exposure Limit. CervoMed announced pharmacokinetic results for its new oral tablet formulation of neflamapimod. The company also secured the FDA's removal of a drug exposure limit, a regulatory update that may affect future development steps. These developments provide context for the stock's recent price movement within its 52-week range.